Oncology, answered.


SABCS 2026

December 8 - 11, 2026

San Antonio, Texas

Real-world evidence for your highest-stakes hematology decision

Answer your most complex questions with real-world data on nearly 600K patients with hematologic malignancies, paired with deep clinical expertise and AI-powered insights.

Learn more about how real-world evidence is advancing breast cancer research and access to care

Preview our research at SABCS 2026

At SABCS 2026, our accepted research showcases the breadth of questions real-world evidence can answer — from understanding  why patients start, stop, or switch therapy to assessing real-world outcomes and treatment patterns in biomarker-defined breast cancer cohorts.

Poster presentations


Leveraging Large Language Models to Characterize Menopausal Symptom Management in Early HR+/HER2- Breast Cancer: A Real-World EHR Study

Author affiliations:  Yale, Flatiron Health

Presentation Number: P1-10-19
Room: Exhibit Hall
Date: Wednesday, December 9, 2026
Time: 12:30 PM–2:00 PM CST

Emerging ESR1 Mutations After First-Line Aromatase Inhibitor (AI) + Cyclin-Dependent Kinase 4/6 Inhibitor (CDK4/6i) in ER+ Metastatic Breast Cancer: Real-World Outcomes and Treatment Patterns

Author affiliations: Flatiron, AstraZeneca

Presentation Number: P4-14-03
Room: Exhibit Hall
Date: Thursday, December 10, 2026
Time: 5:00 PM–6:30 PM CST

Increasing Yet Underutilized: Real-World ESR1 Testing and Liquid Biopsy Uptake During First-line Aromatase Inhibitor (AI) + Cyclin-Dependent Kinase 4/6 inhibitor (CDK4/6i) Therapy in Metastatic Breast Cancer (mBC)

Author affiliations: Flatiron, AstraZeneca

Presentation Number: P4-13-20 
Room: Exhibit Hall
Date: Thursday, December 10, 2026
Time: 5:00 PM–6:30 PM CST

Factors Influencing First-Line (1L) cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) Utilization in HR+ HER2- Metastatic Breast Cancer (mBC): Insights from Clinician Documentation

Author affiliations: Flatiron, Novartis

Presentation Number: P4-14-20  
Room: Exhibit Hall
Date: Thursday, December 10, 2026
Time: 5:00 PM–6:30 PM CST